These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11785102)

  • 1. [Activity of cathepsin H in blood and biopsies of patients with precancerous conditions and mouth cancer].
    Popova AN; Zhloba AA; Solov'ev MM
    Vopr Onkol; 2001; 47(5):590-4. PubMed ID: 11785102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
    Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
    Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cysteine cathepsins secreted into the blood as markers of tumor growth].
    Zhloba AA; Dunaevskiĭ VA
    Vopr Onkol; 1996; 42(1):70-6. PubMed ID: 8686249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
    Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
    Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation processing of cathepsin H impairs recognition by its propeptide.
    Horn M; Dolecková-Maresová L; Rulísek L; Mása M; Vasiljeva O; Turk B; Gan-Erdene T; Baudys M; Mares M
    Biol Chem; 2005 Sep; 386(9):941-7. PubMed ID: 16164419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
    Sohar N; Hammer H; Sohar I
    Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The proof of some enzymes in precancerous conditions and tumors of the oral cavity].
    Hornová J; Papousek F
    Cesk Stomatol; 1972 Mar; 72(2):81-5. PubMed ID: 4502322
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human cathepsin H lacking the mini chain is an endopeptidase.
    Vasiljeva O; Dolinar M; Turk V; Turk B
    Biochemistry; 2003 Nov; 42(46):13522-8. PubMed ID: 14621998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sortilin mediates the lysosomal targeting of cathepsins D and H.
    Canuel M; Korkidakis A; Konnyu K; Morales CR
    Biochem Biophys Res Commun; 2008 Aug; 373(2):292-7. PubMed ID: 18559255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cathepsin H: deletion of the mini-chain switches substrate specificity from aminopeptidase to endopeptidase.
    Dodt J; Reichwein J
    Biol Chem; 2003 Sep; 384(9):1327-32. PubMed ID: 14515996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.
    Schweiger A; Christensen IJ; Nielsen HJ; Sørensen S; Brünner N; Kos J
    Int J Biol Markers; 2004; 19(4):289-94. PubMed ID: 15646835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precancerous and cancerous lesions of the oral cavity].
    Loeb I; Evrard L
    Rev Med Brux; 2008 Sep; 29(4):267-72. PubMed ID: 18949975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of cathepsins S and H in pleural fluids of inflammatory and neoplastic origin.
    Bunatova K; Obermajer N; Kotyza J; Pesek M; Kos J
    Int J Biol Markers; 2009; 24(1):47-51. PubMed ID: 19404922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal cysteine peptidases and malignant tumours.
    Kirschke H
    Adv Exp Med Biol; 1997; 421():253-7. PubMed ID: 9330705
    [No Abstract]   [Full Text] [Related]  

  • 16. Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions.
    Poh CF; Ng S; Berean KW; Williams PM; Rosin MP; Zhang L
    J Can Dent Assoc; 2008 Apr; 74(3):283-8. PubMed ID: 18387269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cathepsin H activity in the human brain and human brain neoplasms].
    Chernaia VI; Reva AD
    Ukr Biokhim Zh (1978); 1989; 61(5):47-50. PubMed ID: 2588347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.
    Segawa E; Sakurai K; Kishimoto H; Takaoka K; Noguchi K; Hashitani S; Hirota S; Urade M
    Oral Oncol; 2008 Jul; 44(7):664-71. PubMed ID: 17996482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
    Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
    Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive search for cysteine cathepsins in the human genome.
    Rossi A; Deveraux Q; Turk B; Sali A
    Biol Chem; 2004 May; 385(5):363-72. PubMed ID: 15195995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.